OncLive
OncLive, Plainsboro, NJ. 16K likes. OncLive covers every angle of your oncology practice, from new technology to treatment advances to important regulatory decisions
OncLive, Plainsboro, NJ. 16K likes. OncLive covers every angle of your oncology practice, from new technology to treatment advances to important regulatory decisions
Christian Marth, MD, PhD, discusses outcomes for key subgroups treated with first-line pembrolizumab and lenvatinib in advanced or recurrent endometrial cancer.
We brought back our May Mammogram event this year with @thelarryfitzgeraldfoundation and the Breast Believe Campaign Partnership. A special thank you…
A retrospective cohort study acalabrutinib and zanubrutinib are being increasingly adopted for the treatment of CLL/SLL in the community setting.
Rebecca Kristeleit, BSc, MBChB, MRCP, PhD, shares post-progression and updated survival outcomes with frontline rucaparib maintenance in ovarian cancer.
Randomized trials are widely recognized to play a pivotal role in the decision-making associated with the establishment of clinical guidelines.
Experts on mantle cell lymphoma discuss third-line treatment options available for patients.
Joshua K. Sabari, MD, reviews data from the 5-year overall survival update from the POSEIDON study investigating durvalumab, tremelimumab, and chemotherapy in first-line metastatic non–small…
Premal Thaker, MD, MS, discusses how the RAMP-201 trial paved a way for the RAMP-301 trial of avutometinib/defactinib in low-grade serous ovarian cancer.
In case you missed any, below is a recap of every episode of OncLive On Air that aired in March 2024.
The current health care economy has driven many employers to self-funding models to offer affordable health care coverage to employees.